The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) in newly diagnosed multiple myeloma (NDMM): Outcomes in patients with 1q21+ status in the phase 3 IMROZ study.
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; GlaxoSmithKline; Janssen-Cilag; Novartis; Oncopeptides; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Meral Beksac
Consulting or Advisory Role - BMS Turkey (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Oncopeptides (Inst); Pfizer (Inst); Sanofi (Inst); Takeda (Inst)
Speakers' Bureau - BMS Turkey (Inst); Menarini (Inst); Sanofi (Inst); Takeda (Inst)
 
Ludek Pour
No Relationships to Disclose
 
Roman Hajek
Honoraria - Janssen, Amgen, Celgene, Novartis, Takeda, BMS
Consulting or Advisory Role - Janssen, Amgen, Celgene, Novartis, Takeda, BMS, AbbVie, PharmaMar
Research Funding - Janssen, Amgen, Celgene, BMS, Novartis, Takeda
Travel, Accommodations, Expenses - Amgen, Celgene, Takeda, Janssen, AbbVie
 
Zhuogang Liu
No Relationships to Disclose
 
Jiri Minarik
Honoraria - Amgen, BMS, Celgene, Janssen, Sanofi, GSK, Pfizer
Consulting or Advisory Role - Amgen, BMS, Celgene, Janssen, Sanofi, GSK, Pfizer
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
 
Joanna Romejko-Jarosinska
Consulting or Advisory Role - SWIXX, ABBVIE
Speakers' Bureau - SWIXX, ABBVIE
Research Funding - ASTRA ZANECA, SANOFI, GENMAB, Innate Pharma, PFEIZER, 4SC AG,Janssen CILAG,GSK
Travel, Accommodations, Expenses - SWIXX, GILEAD, TAKEDA, ABBVIE,
 
Ivan Spicka
Consulting or Advisory Role - BMS, Amgen, Johnson and Johnson, Takeda, Sanofi, GSK
Speakers' Bureau - Amgen, Johnson and Johnson, Takeda, BMS, Sanofi
Travel, Accommodations, Expenses - Johnson and Johnson, BMS, Sanofi
 
Vladimir Vorobyev
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Janssen Oncology; Novartis; Roche; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; BeiGene; BioCad; BMSi; Janssen; MSD; Novartis; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Elena Zamagni
Honoraria - Janssen, Bristol-Myers Squibb, Sanofi, Amgen, GlaxoSmithKline, Pfizer, Oncopeptides, Menarini-Stemline
Consulting or Advisory Role - Janssen, Bristol-Myers Squibb, Sanofi, Amgen, GlaxoSmithKline, Pfizer, Oncopeptides, Menarini-Stemline
 
Hartmut Goldschmidt
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Oncopeptides; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); GlaxoSmithKline; Janssen-Cilag (Inst); Sanofi (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); GlycoMimetics Inc. (Inst); Heidelberg Pharma (Inst); Janssen Research & Development (Inst); Millenium Pharamceuticals (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen-Cilag; Oncopeptides; Pfizer; Sanofi
 
Thomas Martin
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Lilly; Pfizer
Research Funding - AMGEN (Inst); BMSi; Janssen Oncology (Inst); Sanofi (Inst)
 
Robert Orlowski
Stock and Other Ownership Interests - Asylia Therapeutics, Inc.
Consulting or Advisory Role - BioTheryX; Bristol-Myers Squibb; GlaxoSmithKline; IASO Biotherapeutics; Janssen; Lytica Therapeutics; Meridian Therapeutics; Monte Rosa Therapeutics; Regeneron; Sanofi; Takeda
Research Funding - Asylia Therapeutics, Inc. (Inst); CARsgen Therapeutics (Inst); Celgene/Bristol-Myers Squibb (Inst); Exelixis (Inst); Heidelberg Pharma (Inst); Janssen Biotech (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Asylia Therapeutics, Inc.
 
Zandra Klippel
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Umer Khan
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Sandrine Macé
Employment - Sanofi
 
Helgi van de Velde
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Thierry Facon
No Relationships to Disclose